Coenzyme	coenzyme	S_chemicals	O
Q10	q10	O	O
treatment	treatment	O	O
ameliorates	ameliorates	O	O
acute	acute	O	O
cisplatin	cisplatin	S_chemicals	O
nephrotoxicity	nephrotoxicity	O	O
in	in	O	O
mice	mice	O	O
.	.	O	O

The	the	O	O
nephroprotective	nephroprotective	O	O
effect	effect	O	O
of	of	O	O
coenzyme	coenzyme	S_chemicals	O
Q10	q10	O	O
was	was	O	O
investigated	investigated	O	O
in	in	O	O
mice	mice	O	O
with	with	O	O
acute	acute	O	B_disease
renal	renal	O	B_disease
injury	injury	O	S_disease
induced	induced	O	O
by	by	O	O
a	a	O	O
single	single	O	O
i.p	i.p	O	O
.	.	O	O

injection	injection	O	O
of	of	O	O
cisplatin	cisplatin	S_chemicals	O
(	(	O	O
5	5	O	O
mg/kg	mg/kg	O	O
)	)	O	O
.	.	O	O

Coenzyme	coenzyme	S_chemicals	O
Q10	q10	O	O
treatment	treatment	O	O
(	(	O	O
10	10	O	O
mg/kg/day	mg/kg/day	O	O
,	,	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
was	was	O	O
applied	applied	O	O
for	for	O	O
6	6	O	O
consecutive	consecutive	O	O
days	days	O	O
,	,	O	O
starting	starting	O	O
1	1	O	O
day	day	O	O
before	before	O	O
cisplatin	cisplatin	S_chemicals	O
administration	administration	O	O
.	.	O	O

Coenzyme	coenzyme	S_chemicals	O
Q10	q10	O	O
significantly	significantly	O	O
reduced	reduced	O	O
blood	blood	O	O
urea	urea	S_chemicals	O
nitrogen	nitrogen	O	O
and	and	O	O
serum	serum	O	O
creatinine	creatinine	S_chemicals	O
levels	levels	O	O
which	which	O	O
were	were	O	O
increased	increased	O	O
by	by	O	O
cisplatin	cisplatin	S_chemicals	O
.	.	O	O

Coenzyme	coenzyme	S_chemicals	O
Q10	q10	O	O
significantly	significantly	O	O
compensated	compensated	O	O
deficits	deficits	O	O
in	in	O	O
the	the	O	O
antioxidant	antioxidant	S_chemicals	O
defense	defense	O	O
mechanisms	mechanisms	O	O
(	(	O	O
reduced	reduced	B_chemicals	O
glutathione	glutathione	S_chemicals	O
level	level	O	O
and	and	O	O
superoxide	superoxide	B_chemicals	O
dismutase	dismutase	S_chemicals	O
activity	activity	O	O
)	)	O	O
,	,	O	O
suppressed	suppressed	O	O
lipid	lipid	S_chemicals	O
peroxidation	peroxidation	O	O
,	,	O	O
decreased	decreased	O	O
the	the	O	O
elevations	elevations	O	O
of	of	O	O
tumor	tumor	B_chemicals	S_disease
necrosis	necrosis	I_chemicals	S_disease
factor-alpha	factor-alpha	I_chemicals	O
,	,	O	O
nitric	nitric	B_chemicals	O
oxide	oxide	S_chemicals	O
and	and	O	O
platinum	platinum	S_chemicals	O
ion	ion	O	O
concentration	concentration	O	O
,	,	O	O
and	and	O	O
attenuated	attenuated	O	O
the	the	O	O
reductions	reductions	O	O
of	of	O	O
selenium	selenium	S_chemicals	O
and	and	O	O
zinc	zinc	O	O
ions	ions	O	O
in	in	O	O
renal	renal	O	O
tissue	tissue	O	O
resulted	resulted	O	O
from	from	O	O
cisplatin	cisplatin	S_chemicals	O
administration	administration	O	O
.	.	O	O

Also	also	O	O
,	,	O	O
histopathological	histopathological	O	O
renal	renal	O	O
tissue	tissue	O	O
damage	damage	O	O
mediated	mediated	O	O
by	by	O	O
cisplatin	cisplatin	S_chemicals	O
was	was	O	O
ameliorated	ameliorated	O	O
by	by	O	O
coenzyme	coenzyme	S_chemicals	O
Q10	q10	O	O
treatment	treatment	O	O
.	.	O	O

Immunohistochemical	immunohistochemical	O	O
analysis	analysis	O	O
revealed	revealed	O	O
that	that	O	O
coenzyme	coenzyme	S_chemicals	O
Q10	q10	O	O
significantly	significantly	O	O
decreased	decreased	O	O
the	the	O	O
cisplatin-induced	cisplatin-induced	O	O
overexpression	overexpression	O	O
of	of	O	O
inducible	inducible	B_chemicals	O
nitric	nitric	B_chemicals	O
oxide	oxide	B_chemicals	O
synthase	synthase	S_chemicals	O
,	,	O	O
nuclear	nuclear	B_chemicals	O
factor-kappaB	factor-kappab	S_chemicals	O
,	,	O	O
caspase-3	caspase-3	S_chemicals	O
and	and	O	O
p53	p53	O	O
in	in	O	O
renal	renal	O	O
tissue	tissue	O	O
.	.	O	O

It	it	O	O
was	was	O	O
concluded	concluded	O	O
that	that	O	O
coenzyme	coenzyme	S_chemicals	O
Q10	q10	O	O
represents	represents	O	O
a	a	O	O
potential	potential	O	O
therapeutic	therapeutic	O	O
option	option	O	O
to	to	O	O
protect	protect	O	O
against	against	O	O
acute	acute	O	O
cisplatin	cisplatin	S_chemicals	O
nephrotoxicity	nephrotoxicity	O	O
commonly	commonly	O	O
encountered	encountered	O	O
in	in	O	O
clinical	clinical	O	O
practice	practice	O	O
.	.	O	O

